Global leader in scientific, toxicological, and regulatory consulting
Intertek Scientific & Regulatory Consultancy (operating as "Cantox Health Sciences International" before acquisition by Intertek in early 2010) is a leading scientific consulting firm with expertise in the areas of Food & Nutrition, Pharmaceutical & Healthcare (formerly offered through Ashuren Health Sciences), Chemicals, and Agri, Biotech & Consumer Products. We specialize in developing scientific and strategic global regulatory plans, resolving complex toxicological and scientific issues, and facilitating timely regulatory approvals.
We have been providing unparalleled service for clients throughout the world for over 25 years and continues to minimize client risk through our broad expertise and knowledge. Our scientific staff comprises more than 80 professionals, including experts in toxicology, global regulatory affairs, chemistry, nutrition, and risk assessment analysis. At Intertek Scientific & Regulatory Consultancy, everything we do begins with solid science. We do it right the first time and we only take those steps that are necessary.
We offer a one-stop shop with the breadth and depth of service to provide the resources clients require when they need them, including additional support to client in-house regulatory and scientific staff. Intertek Scientific & Regulatory Consultancy is committed to hiring some of the best and brightest scientists. We are highly ethical, relationship-oriented, and deliver excellent value by avoiding activities that are unnecessary or that won’t move ahead to a successful outcome.
The Intertek Scientific & Regulatory Consultancy guiding principle has always been to protect client interests while helping our clients achieve their milestones in bringing new products to market, or proactively defending established ones.
Our clients benefit from our cost-effective, value-added services, which:
- Streamlines product development programs and eliminates unnecessary steps
- Addresses scientific issues prior to and during regulatory review
- Allows faster time to market and timely regulatory approvals
Related Links
